These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3109189)

  • 1. Comparison of the malondialdehyde formation in megakaryocytes and platelets after in vivo and in vitro administration of aspirin.
    Saigo K; Ryo R; Nakaya Y; Yamaguchi N
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):138-47. PubMed ID: 3109189
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of malondialdehyde (MDA) formation in thrombocytes].
    Stepanauskas M; Norden C; Heine H; Staak R
    Z Med Lab Diagn; 1982; 23(6):332-8. PubMed ID: 7170826
    [No Abstract]   [Full Text] [Related]  

  • 3. The recovery of platelet malondialdehyde production after a single intake of aspirin--the effect of dosage.
    Takayama H; Okuma M; Uchino H
    Thromb Haemost; 1982 Aug; 48(1):13-7. PubMed ID: 6813990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An ex-vivo technic for the pharmacologic evaluation of potential antiphlogistics by ex-vivo determination of the rate of malondialdehyde (MDA) formation using rat platelets].
    Schmollack W; Scholz U; Bekemeier H
    Pharmazie; 1986 Jun; 41(6):395-7. PubMed ID: 3763681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of factor VIII concentrate on malondialdehyde release by normal human platelets].
    Geroldi D; Cervini L
    Boll Soc Ital Biol Sper; 1979 Apr; 55(7):675-81. PubMed ID: 121702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material.
    Violi F; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Lipids; 1985 May; 20(5):322-4. PubMed ID: 3925272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on platelet kinetics by determination of malondialdehyde after aspirin-ingestion (author's transl)].
    Arai H
    Rinsho Byori; 1980 Oct; 28(10):989-93. PubMed ID: 7253282
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin resistance transient laboratory finding or important clinical entity?
    Lev EI
    J Am Coll Cardiol; 2009 Feb; 53(8):678-80. PubMed ID: 19232900
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex-related difference in the effect of aspirin on prostaglandin metabolism in rat platelet and aorta.
    Morikawa M; Inoue M; Kojima T; Uchiyama K; Tsuboi M
    Biochem Biophys Res Commun; 1981 Nov; 103(1):77-81. PubMed ID: 7032525
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man.
    Cerletti C; Gambino MC; Bucchi F; Rajtar G; Riva E; de Goetano G
    Agents Actions Suppl; 1986; 20():239-48. PubMed ID: 3101444
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of ditazol on human platelets malonylaldehyde (MDA) production.
    Fabris F; Casonato A; Randi M; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):433-8. PubMed ID: 6169605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of heparin on the formation of platelet malondialdehyde].
    Charvát J; Rysánek K; Spánková H
    Cas Lek Cesk; 1985 Mar; 124(12):357-9. PubMed ID: 4005906
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards a better aspirin.
    Vane J
    Nature; 1994 Jan; 367(6460):215-6. PubMed ID: 8121485
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a single dose of acetylsalicylic acid (Colfarit) on prostaglandin synthesis of platelets.
    Rákóczi I; Bagdány S; Szigetvári I; Gáti I
    Ther Hung; 1981; 29(3):128-33. PubMed ID: 7188138
    [No Abstract]   [Full Text] [Related]  

  • 18. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurement of platelet activity in postoperative patients.
    Stulberg BN; Weksler BB; Ranawat CS
    Surg Forum; 1979; 30():489-91. PubMed ID: 538672
    [No Abstract]   [Full Text] [Related]  

  • 20. Malondialdehyde production and the release reaction in rat blood platelets: inhibition by aspirin and indomethacin ex vivo [proceedings].
    Gordon JL; MacIntyre DE; McMillan RM
    Br J Pharmacol; 1976 Oct; 58(2):299P-300P. PubMed ID: 974415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.